These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6100608)

  • 1. The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.
    Clauser E; Gonzalez MF; Bouhnik J; Corvol P; Ménard J
    J Hypertens Suppl; 1983 Oct; 1(1):37-40. PubMed ID: 6100608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats.
    Jaramillo HN; Sambhi MP; Bouhnik J; Corvol P; Menard J
    Endocrinology; 1987 Apr; 120(4):1384-90. PubMed ID: 3030698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in angiotensinogen and des-angiotensin I-angiotensinogen in man and rat upon inhibition of converting enzyme].
    Clauser E; Genain C; Bouhnik J; Corvol P; Ménard J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():157-61. PubMed ID: 6287956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen.
    Clauser E; Bouhnik J; Gonzalez MF; Corvol P; Menard J
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E129-33. PubMed ID: 6320670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat.
    Radziwill R; Stuzmann M; Hilgenfeldt U; Hackenthal E
    Eur J Pharmacol; 1986 Mar; 122(1):59-64. PubMed ID: 3007179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.
    Zusman RM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):13-23. PubMed ID: 3037886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
    Jover B; Dupont M; Casellas D; Mimran A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
    Wilkes BM
    J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
    Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC
    Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the renin-angiotensin system in blood pressure regulation in normotensive animals and man.
    Corvol P; Michel JB; Evin G; Gardes J; Bensala-Alaoui A; Ménard J
    J Hypertens Suppl; 1984 Dec; 2(2):S25-30. PubMed ID: 6100873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variations of the renin aldosterone system in Cushing's disease (author's transl)].
    Bricaire H; Thibonnier M; Hautecouverture M; Corvol P; Luton JP
    Nouv Presse Med; 1980 Mar; 9(14):1007-9. PubMed ID: 6988802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct radioimmunoassays of renin and renin substrate during converting-enzyme inhibition.
    Genain C; Aldigier JC; Guyenne TT; Corvol P; Ménard J
    Clin Exp Hypertens A; 1982; 4(11-12):2193-202. PubMed ID: 6293741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
    Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC
    Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.